Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yumi Nakamoto is active.

Publication


Featured researches published by Yumi Nakamoto.


Bioorganic & Medicinal Chemistry | 2009

Design, synthesis, and SAR of cis-1,2-diaminocyclohexane derivatives as potent factor Xa inhibitors. Part II: Exploration of 6–6 fused rings as alternative S1 moieties

Kenji Yoshikawa; Shozo Kobayashi; Yumi Nakamoto; Noriyasu Haginoya; Satoshi Komoriya; Toshiharu Yoshino; Tsutomu Nagata; Akiyoshi Mochizuki; Kengo Watanabe; Makoto Suzuki; Hideyuki Kanno; Toshiharu Ohta

A series of cis-1,2-diaminocyclohexane derivatives were synthesized with the aim of optimizing previously disclosed factor Xa (fXa) inhibitors. The exploration of 5-6 fused rings as alternative S1 moieties resulted in two compounds which demonstrated improved solubility and reduced food effect compared to the clinical candidate, compound A. Herein, we describe the synthesis and structure-activity relationship (SAR), together with the physicochemical properties and pharmacokinetic (PK) profiles of some prospective compounds.


Bioorganic & Medicinal Chemistry | 2006

Design, synthesis, and biological activity of novel factor Xa inhibitors: improving metabolic stability by S1 and S4 ligand modification.

Satoshi Komoriya; Shozo Kobayashi; Ken Osanai; Toshiharu Yoshino; Tsutomu Nagata; Noriyasu Haginoya; Yumi Nakamoto; Akiyoshi Mochizuki; Takayasu Nagahara; Makoto Suzuki; Takashi Shimada; Kengo Watanabe; Yumiko Isobe; Taketoshi Furugoori


Bioorganic & Medicinal Chemistry Letters | 2008

Design, synthesis, and biological activity of piperidine diamine derivatives as factor Xa inhibitor.

Akiyoshi Mochizuki; Yumi Nakamoto; Hiroyuki Naito; Kouichi Uoto; Toshiharu Ohta


Archive | 2008

Drug compositions and methods for preventing and treating thrombosis or embolism

Toshiharu Ohta; Satoshi Komoriya; Toshiharu Yoshino; Kouichi Outo; Yumi Nakamoto; Hiroyuki Naito; Akiyoshi Mochizuki; Tsutomu Nagata; Hideyuki Kanno; Noriyasu Haginoya; Kenji Yoshikawa; Masatoshi Nagamochi; Syozo Kobayashi; Makoto Ono


Archive | 2003

Novel ethylenediamine derivatives

Yumi Nakamoto; Toshiharu Yoshino; Hiroyuki Naito; Tsutomu Nagata; Kenji Yoshikawa; Makoto Suzuki


Heterocycles | 2008

Enantioselective synthesis of piperidine diamine derivatives as novel fXa inhibitors

Akiyoshi Mochizuki; Hiroyuki Naito; Yumi Nakamoto; Kouichi Uoto; Toshiharu Ohta


Archive | 2003

Antithrombotic diaminocyclohexane derivatives

Toshiharu Ohta; Satoshi Komoriya; Toshiharu Yoshino; Kouichi Uoto; Yumi Nakamoto; Hiroyuki Naito; A. Daiichi Pharmaceutical Co. Ltd Mochizuki; Tsutomu Nagata; Hideyuki Kanno; Noriyasu Haginoya; Kenji Yoshikawa; M Daiichi Pharmaceutical Co. Ltd Nagamochi; Syozo Kobayashi; Makoto Ono


Archive | 2010

3-(biaryloxy) propionic acid derivative

Tatsuya Nishi; Yumi Nakamoto; Yuichi Ochiai; Ryoko Kitazawa; Masashi Hasegawa; Hiroshi Susaki


Archive | 2010

3-(ビアリールオキシ)プロピオン酸誘導体

Tatsuya Nishi; 達矢 西; Masashi Hasegawa; 雅司 長谷川; Yumi Nakamoto; 有美 中本; Yuichi Ochiai; 雄一 落合; Ryoko Kitazawa; 亮子 北澤; Hiroshi Susaki; 浩 洲崎


Archive | 2010

3-(biaryloxy)propionic acid derivatives for prevention and/or treatment of thromboembolic diseases

Tatsuya Nishi; Masashi Hasegawa; Yumi Nakamoto; Yuichi Ochiai; Ryoko Kitazawa; Hiroshi Susaki

Collaboration


Dive into the Yumi Nakamoto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge